Hyperparathyroidism and bone disease after renal transplantation (CROSBI ID 168411)
Prilog u časopisu | pregledni rad (stručni)
Podaci o odgovornosti
Pavlović, Draško ; Orlić Lidija
engleski
Hyperparathyroidism and bone disease after renal transplantation
Metabolic bole disease is one of the most frequent complications of chronic renal failure. Numerous disorders leading to the metabolic bone disease can be reversed by successful renal transplantation. However, in some patients, in spite of satisfactory renal fuction, some disorder may persist for months after successful transplantation, e.g. increased parathyroid hormone secretion. Besides, drugs used in immunossuppresive therapy may cause metabolic bone disease or reduction bone mass. Therefore, significant loss of mass take place in the majority of patients during the first six months. Among drugs used in the prevention of bone disease after transplantation of solid organs the most important role have biphosphonates and vitamin D, i.e. calcitriol.
kidney transplantation; metabolic bone disease
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano